The HTAC recommends the emergency use of Janssen Ad26.COV2.S (COVID-19) Vaccine to prevent COVID-19 for persons aged 18 and older. Johnson and Johnson COVID-19 Vaccine under Emergency Use The emergency use authorization of the Food and Drug Administration (FDA) (dated 16 April 2021) allows for timely access of COVID-19 vaccines for Filipinos during the pandemic. continue reading : HTAC Guidance for the General Public : COVID-19 Vaccine Janssen
Preliminary Recommendation on Lapatinib
Document link: MEDICINES RECOMMENDED FOR NON-INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 14 June 2021.) Document Preview:
Evidence brief for 22 May to 28 May 2021
For the period of 22 May to 28 May 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 22 May to 28 May 2021
HTAC Recommends COVID-19 Vaccine Moderna Under Emergency Use for Reducing COVID-19 Risk in Persons Aged 18 and Older
Date of publication: May 28, 2021 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of COVID-19 Vaccine Moderna. This assessment follows the continue reading : HTAC Recommends COVID-19 Vaccine Moderna Under Emergency Use for Reducing COVID-19 Risk in Persons Aged 18 and Older